Skip to main content

Table 2 Effectiveness of the modified MCTKD and the retention rates at 1, 3 and 6 months of follow-up

From: Efficacy and safety of modified medium-chain triglyceride ketogenic diet in patients with drug-resistant epilepsy

  

1 month

3 months

6 months

Groups

cases

Responder rate (%)

Seizure freedom(%)

Retention rate(%)

Responder rate(%)

Seizure freedom(%)

Retention rate(%)

Responder rate(%)

Seizure freedom(%)

Retention rate(%)

 < 10 years

38

17 (44.7%)

3 (7.9%)

37 (97.4%)

15 (39.5%)

3 (7.9%)

21 (55.3%)

14 (36.8%)

2 (5.3%)

14 (36.8%)

10-18years

31

12 (38.7%)

3 (9.7%)

30 (96.8%)

13 (41.9%)

3 (9.7%)

22 (71.0%)

11 (35.5%)

2 (6.5%)

12 (38.7%)

 ≥ 18 years

54

32 (59.3%)

9 (16.7%)

54 (100.0%)

25 (46.3%)

7 (13.0%)

37 (68.5%)

13 (24.1%)

4 (7.4%)

15 (27.8%)

total

123

61 (49.6%)

15 (12.2%)

121 (98.4%)

53 (43.1%)

13 (10.6%)

80 (65.0%)

38 (30.9%)

8 (6.5%)

41 (33.3%)

P value

 

0.144

0.465

0.313

0.823

0.756

0.315

0.354

1.000

0.523